These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3515357)

  • 1. Modification of immunogenicity of transfusion products.
    Deeg HJ
    Prog Clin Biol Res; 1986; 211():117-27. PubMed ID: 3515357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
    Bean MA; Graham T; Appelbaum FR; Deeg HJ; Schuening F; Sale GE; Storb R
    Transplantation; 1994 Feb; 57(3):423-6. PubMed ID: 8108879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.
    Deeg HJ; Aprile J; Graham TC; Appelbaum FR; Storb R
    Blood; 1986 Feb; 67(2):537-9. PubMed ID: 3510683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.
    Bean MA; Storb R; Graham T; Raff R; Sale GE; Schuening F; Appelbaum FR
    Transplantation; 1991 Dec; 52(6):956-60. PubMed ID: 1836286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
    Storb R; Raff RF; Appelbaum FR; Schuening FW; Sandmaier BM; Graham TC
    Transplantation; 1988 Aug; 46(2):334-6. PubMed ID: 3043788
    [No Abstract]   [Full Text] [Related]  

  • 8. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marrow graft rejection in DLA-identical canine littermates: antigens involved are expressed on leukocytes and skin epithelial cells but probably not on platelets and red blood cells.
    Storb R; Deeg HJ; Weiden PL; Graham TC; Atkinson KA; Slichter SJ; Thomas ED
    Transplant Proc; 1979 Mar; 11(1):504-6. PubMed ID: 377686
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of renal allograft survival in DLA-tissue typed beagles after third-party leucocyte and erythrocyte transfusion.
    Obertop H; Bijnen AB; Schreve RH; Westbroek DL
    Proc Eur Dial Transplant Assoc; 1979; 16():366-71. PubMed ID: 398508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion: the distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient.
    Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Miyanari N; Mori K; Ogawa M
    J Surg Res; 1996 Feb; 61(1):23-9. PubMed ID: 8769937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype.
    Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW
    Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological studies on renal transplantation in rats. Effects of pretransplant blood transfusion on renal graft survival].
    Ueda H
    Hinyokika Kiyo; 1985 Dec; 31(12):2169-82. PubMed ID: 3914214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of class-II major histocompatibility complex (MHC)-antigen-positive donor leukocytes in transfusion-induced alloimmunization to donor class-I MHC antigens.
    Kao KJ; del Rosario ML
    Blood; 1998 Jul; 92(2):690-4. PubMed ID: 9657772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R; Beckham C; Storb R; Deeg HJ
    Transplantation; 1994 Dec; 58(12):1366-71. PubMed ID: 7809930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.